Collaborations

Mike Murphy, FMedSci  
MRC Mitochondrial Biology Unit & Department of Medicine, University of Cambridge, UK
http://www.mrc-mbu.cam.ac.uk/people/mike-murphy

Mitochondrial Therapies Group (MTG)
MTG brings together chemists, biochemists and clinicians to enable rational design, synthesis and testing of novel diagnostic and therapeutic compounds that target mitochondria.
https://www.mitotherapy.co.uk

BHF Cambridge Centre for Cardiovascular Research Excellence

Ana Vujic, Group leader
Victor Phillip Dahdaleh Heart & Lung Research Institute, University of Cambridge, UK
https://www.hlri.cam.ac.uk/investigators/ana-vujic/
​
Antonio Vidal-Puig MD PhD FRCP FMedSci EMBA
MRC Metabolic Disease Unit, University of Cambridge, UK
Sanger Institute
​https://www.tvplab-cambridge.com/
​https://www.sanger.ac.uk/person/vidal-puig-antonio/
 
Zhelong Xu
Tianjin Medical University, China

James Downey
University of South Alabama, USA